Evolent Health, Inc (EVH): Price and Financial Metrics

Evolent Health, Inc (EVH): $26.56

-0.17 (-0.64%)

POWR Rating

Component Grades














  • Growth is the dimension where EVH ranks best; there it ranks ahead of 75.69% of US stocks.
  • The strongest trend for EVH is in Stability, which has been heading up over the past 48 weeks.
  • EVH's current lowest rank is in the Quality metric (where it is better than 16.33% of US stocks).

EVH Stock Summary

  • EVH's went public 6.31 years ago, making it older than merely 22.48% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of -20.07%, Evolent Health Inc's debt growth rate surpasses just 24.77% of about US stocks.
  • Over the past twelve months, EVH has reported earnings growth of -91.85%, putting it ahead of merely 20.55% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Evolent Health Inc, a group of peers worth examining would be WRLD, IMAC, HLIO, WWW, and MLI.
  • EVH's SEC filings can be seen here. And to visit Evolent Health Inc's official web site, go to www.evolenthealth.com.

EVH Valuation Summary

  • In comparison to the median Technology stock, EVH's price/sales ratio is 59.63% lower, now standing at 2.2.
  • EVH's price/earnings ratio has moved up 3.2 over the prior 76 months.
  • Over the past 76 months, EVH's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for EVH.

Stock Date P/S P/B P/E EV/EBIT
EVH 2021-09-01 2.2 3.5 -30.6 -54.1
EVH 2021-08-31 2.2 3.5 -30.2 -53.6
EVH 2021-08-30 2.2 3.5 -30.2 -53.4
EVH 2021-08-27 2.2 3.5 -30.0 -53.1
EVH 2021-08-26 2.1 3.4 -29.5 -52.2
EVH 2021-08-25 2.1 3.4 -29.4 -52.2

EVH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EVH has a Quality Grade of D, ranking ahead of 16.33% of graded US stocks.
  • EVH's asset turnover comes in at 0.726 -- ranking 208th of 556 Business Services stocks.
  • BB, NSP, and MAN are the stocks whose asset turnover ratios are most correlated with EVH.

The table below shows EVH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.726 0.244 -0.113
2021-03-31 0.742 0.245 -0.547
2020-12-31 0.746 0.228 -0.601
2020-09-30 0.704 0.220 -0.869
2020-06-30 0.636 0.223 -0.795
2020-03-31 0.567 0.227 -0.540

EVH Price Target

For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $28.33 Average Broker Recommendation 1.5 (Moderate Buy)

EVH Stock Price Chart Interactive Chart >

Price chart for EVH

EVH Price/Volume Stats

Current price $26.56 52-week high $26.86
Prev. close $26.73 52-week low $9.44
Day low $25.87 Volume 223,614
Day high $26.77 Avg. volume 531,518
50-day MA $24.27 Dividend yield N/A
200-day MA $20.58 Market Cap 2.32B

Evolent Health, Inc (EVH) Company Bio

Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.

EVH Latest News Stream

Event/Time News Detail
Loading, please wait...

EVH Latest Social Stream

Loading social stream, please wait...

View Full EVH Social Stream

Latest EVH News From Around the Web

Below are the latest news stories about Evolent Health Inc that investors may wish to consider to help them evaluate EVH as an investment opportunity.

Evolent Health Exceeds Quality Standards and Saves Medicare $21 Million through its Medicare Shared Savings Program ACO

Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, announced today that its Evolent Care Partners (ECP) business unit saved Medicare more than $21 million in 2020, its inaugural year as the owner of an accountable care organization (ACO). ECP and the independent physician participants in its ACO network will receive $15.8 million in shared savings for exceeding quality and cost targets in 2020, according to

Yahoo | August 30, 2021

Evolent Health to Participate in Upcoming Investor Conferences

Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer and Co-Founder Seth Blackley and Chief Financial Officer John Johnson will participate in upcoming investor conferences.

Yahoo | August 26, 2021

Evolent Health (EVH) Q2 2021 Earnings Call Transcript

EVH earnings call for the period ending June 30, 2021.

Yahoo | August 5, 2021

Evolent Health (EVH) Reports Q2 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of 66.67% and 2.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 4, 2021

Evolent Health Announces Agreement to Acquire Vital Decisions, Expanding its Depth and Breadth in Specialty Care Management

Evolent Health, Inc. (NYSE: EVH) – Evolent Health, Inc. ("Evolent"), and WindRose Health Investors ("WindRose") announced today that they have entered into a definitive agreement for Evolent to acquire WindRose's portfolio company Vital Decisions for $85 million, with an additional earn out of up to $45 million. Vital Decisions will report into Evolent's specialty management offering, New Century Health, and will be consolidated into Evolent's Clinical Solutions segment.

Yahoo | August 4, 2021

Read More 'EVH' Stories Here

EVH Price Returns

1-mo 9.03%
3-mo 25.76%
6-mo 28.50%
1-year 115.76%
3-year -6.48%
5-year 13.26%
YTD 65.69%
2020 77.13%
2019 -54.64%
2018 62.20%
2017 -16.89%
2016 22.21%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 6.4267 seconds.